A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
NCT03568578
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
450
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B
Liver Fibrosis
Interventions
DRUG:
Entecavir 0.5 mg
DRUG:
Anluohuaxian Pill 12g
Sponsor
Peking University First Hospital